BeiGene’s Sonrotoclax was granted FDA orphan designation as a treatment of multiple myeloma, according to a post to the agency’s website.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on BGNE:
